Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

259 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Resistance to alkylating agents and cisplatin: insights from ovarian carcinoma model systems.
Perez RP, Hamilton TC, Ozols RF. Perez RP, et al. Among authors: ozols rf. Pharmacol Ther. 1990;48(1):19-27. doi: 10.1016/0163-7258(90)90015-t. Pharmacol Ther. 1990. PMID: 2274575 Review.
Augmentation of adriamycin, melphalan, and cisplatin cytotoxicity in drug-resistant and -sensitive human ovarian carcinoma cell lines by buthionine sulfoximine mediated glutathione depletion.
Hamilton TC, Winker MA, Louie KG, Batist G, Behrens BC, Tsuruo T, Grotzinger KR, McKoy WM, Young RC, Ozols RF. Hamilton TC, et al. Among authors: ozols rf. Biochem Pharmacol. 1985 Jul 15;34(14):2583-6. doi: 10.1016/0006-2952(85)90551-9. Biochem Pharmacol. 1985. PMID: 4040369 No abstract available.
Relationship between platinum-DNA adduct formation and removal and cisplatin cytotoxicity in cisplatin-sensitive and -resistant human ovarian cancer cells.
Johnson SW, Swiggard PA, Handel LM, Brennan JM, Godwin AK, Ozols RF, Hamilton TC. Johnson SW, et al. Among authors: ozols rf. Cancer Res. 1994 Nov 15;54(22):5911-6. Cancer Res. 1994. PMID: 7954422
Multidrug resistance in ovarian cancer.
Fojo A, Hamilton TC, Young RC, Ozols RF. Fojo A, et al. Among authors: ozols rf. Cancer. 1987 Oct 15;60(8 Suppl):2075-80. doi: 10.1002/1097-0142(19901015)60:8+<2075::aid-cncr2820601521>;2-f. Cancer. 1987. PMID: 3308067 Review.
Increased DNA repair as a mechanism of acquired resistance to cis-diamminedichloroplatinum (II) in human ovarian cancer cell lines.
Masuda H, Ozols RF, Lai GM, Fojo A, Rothenberg M, Hamilton TC. Masuda H, et al. Among authors: ozols rf. Cancer Res. 1988 Oct 15;48(20):5713-6. Cancer Res. 1988. PMID: 3139281
Mechanisms of resistance to cisplatin and alkylating agents.
Hamilton TC, Lai GM, Rothenberg ML, Fojo AT, Young RC, Ozols RF. Hamilton TC, et al. Among authors: ozols rf. Cancer Treat Res. 1989;48:151-69. doi: 10.1007/978-1-4613-1601-5_10. Cancer Treat Res. 1989. PMID: 2577136 Review. No abstract available.
Collateral susceptibility of adriamycin-, melphalan- and cisplatin-resistant human ovarian tumor cells to bleomycin.
Tsuruo T, Hamilton TC, Louie KG, Behrens BC, Young RC, Ozols RF. Tsuruo T, et al. Among authors: ozols rf. Jpn J Cancer Res. 1986 Sep;77(9):941-5. Jpn J Cancer Res. 1986. PMID: 2429947
Effect of glutathione on DNA repair in cisplatin-resistant human ovarian cancer cell lines.
Lai GM, Ozols RF, Young RC, Hamilton TC. Lai GM, et al. Among authors: ozols rf. J Natl Cancer Inst. 1989 Apr 5;81(7):535-9. doi: 10.1093/jnci/81.7.535. J Natl Cancer Inst. 1989. PMID: 2493524
Counterpoint: Intraperitoneal chemotherapy: an investigational treatment in ovarian cancer.
Ozols RF. Ozols RF. J Natl Compr Canc Netw. 2004 Nov;2(6):555-60. doi: 10.6004/jnccn.2004.0046. J Natl Compr Canc Netw. 2004. PMID: 19780299 Review.
Gynecologic Oncology Group (GOG-USA) trials in ovarian cancer.
Ozols RF. Ozols RF. Adv Exp Med Biol. 2008;622:131-43. doi: 10.1007/978-0-387-68969-2_11. Adv Exp Med Biol. 2008. PMID: 18546624 Review. No abstract available.
259 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page